Palace studying legal basis for Duterte's inoculation of Sinopharm vaccine


Presidential spokesperson Harry Roque on Thursday said the Malacañang legal office is determining whether the compassionate special permit granted to Sinopharm could be used as a basis for President Rodrigo Duterte to use their vaccine.

"They are studying kung pupuwedeng gamitin iyong compassionate use para legal basis for the President to have the Sinopharm vaccine. But it is still being studied by the Malacañang legal office," Roque said at a Palace press briefing.

"If you ask me as a lawyer, he is the commander-in-chief of the Armed Forces of the Philippines and he should be allowed to use the Sinopharm under the compassionate use license," he added.

Roque has bared that the President prefers


to be vaccinated against COVID-19 with China's Sinopharm vaccine.

The Food and Drug Administration (FDA) has approved the compassionate use of the Sinopharm vaccine for the benefit of the Presidential Security Group (PSG) members.

PSG is under the AFP.

Sinopharm has yet to apply for an emergency use authorization (EUA) which would allow the pharmaceutical firm to bring its vaccine to the Philippines for the use of public.—AOL, GMA News